CNS Pharmaceuticals (NASDAQ:CNSP) is back on every biotech watchlist after a 242.36% one-week ramp tied to its Berubicin ...

Biotech ETFs can help investors capitalize on health care innovation while avoiding the boom-or-bust nature of individual ...

In a letter to President Donald Trump, a group of biotech executives recommended former cancer regulator Richard Pazdur to ...

Significant news coverage and COVID-19 flashbacks have driven investors into biotech stocks over the past week.

Quick Read Biotech dealmaking has accelerated as pharmaceutical giants face looming patent cliffs and hunt for growth. Five ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Dr. Andrew Snyder (Monash University) joins the show to discuss the current biotech landscape: rising M&A and IPO activity, ...

Kyle Diamantas, the acting commissioner of the FDA, is expected to be a drama-free, stabilizing caretaker at the top of the ...

Biotechnology stocks are among the most high-risk, high-reward stocks in the market. Many biotech companies are working to ...

Isomorphic Labs, which hasn’t yet disclosed a molecule or reached the clinic, breaks the recent trend of investors putting ...

Inovio Pharmaceuticals and Novavax stocks pare back earlier gains as the rally loses enthusiasm. Following a robust rally, Moderna appears to be regaining leadership within the biotech space. This ...

BioHub Maryland's partnership with NIBRT provides specialized training, targeting veterans and addressing talent shortages.